The societal value of universal childhood vaccination

被引:29
作者
Chabot, I [1 ]
Goetghebeur, MM
Grégoire, JP
机构
[1] Merck Frosst Canada Inc, Dept Hlth Econ & Outcomes Res, Kirkland, PQ, Canada
[2] BioMedCom Consultants Inc, Montreal, PQ, Canada
[3] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[4] Quebec Univ Hosp, Populat Hlth Res Unit, Quebec City, PQ, Canada
关键词
childhood vaccines; cost-effectiveness; society;
D O I
10.1016/j.vaccine.2003.10.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Availability of new vaccines preventing infectious diseases in healthy children populations is increasing worldwide. In Canada, despite the current recommendation of the National Advisory Committee on Immunization to include recent vaccines in routine schedule, only a few provinces have incorporated some of the newer vaccines in routine vaccination programs. A review was undertaken of economic evaluations of childhood vaccination strategies performed from the societal point of view in industrialized countries, to gain perspective on their global benefits. The general trend supports most universal vaccination programs as cost-saving or cost-effective for society. Comparison of vaccination programs with other health care interventions indicates that vaccines are often one of society's best healthcare investments. Current data suggest that the Canadian society would benefit from a more complete immunization program. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1992 / 2005
页数:14
相关论文
共 64 条
[11]   Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services [J].
Carande-Kulis, VG ;
Maciosek, MV ;
Briss, PA ;
Teutsch, SM ;
Zaza, S ;
Truman, BI ;
Messonnier, ML ;
Pappaioanou, M ;
Harris, JR ;
Fielding, J .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2000, 18 (01) :75-91
[12]  
*COMM DEP HUM SERV, 1995, GUID PHARM IND PERP
[13]   The cost of a food-borne outbreak of hepatitis A in Denver, Colo [J].
Dalton, CB ;
Haddix, A ;
Hoffman, RE ;
Mast, EE .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (09) :1013-1016
[14]   Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec [J].
De Wals, P ;
Erickson, L .
VACCINE, 2002, 20 (21-22) :2840-2844
[15]   A cost benefit analysis of routine varicella vaccination in Spain [J].
Domingo, JD ;
Ridao, M ;
Latour, J ;
Ballester, A ;
Morant, A .
VACCINE, 1999, 17 (11-12) :1306-1311
[16]   Vaccination coverage of 2-year-old children and immunization practices - Canada, 1994 [J].
Duclos, P .
VACCINE, 1997, 15 (01) :20-24
[17]   The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales [J].
Edmunds, WJ ;
Brisson, M ;
Rose, JD .
VACCINE, 2001, 19 (23-24) :3076-3090
[18]   Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997 [J].
Ekwueme, DU ;
Strebel, PM ;
Hadler, SC ;
Meltzer, MI ;
Allen, JW ;
Livengood, JR .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (08) :797-803
[19]   Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994 [J].
Erickson, L ;
De Wals, P .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1159-1164
[20]  
ESS SM, 2003, VACCINE, V3813, P1